Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study

Circulation

Volumn 106, Issue 8, 2002, Pages 939-944

  Juul, Anders ^a   Scheike, Thomas ^a   Davidsen, Michael ^a   Gyllenborg, Jesper ^a   Jørgensen, Torben ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Atherosclerosis; Epidemiology; Growth substances; Myocardial infarction

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SMOKING HABIT;

ADULT; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037143639     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000027563.44593.CC     Document Type: Article

References (26)

1. The insulin-like growth factors: Their putative role in atherogenesis
2. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
3. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
4. Premature mortality due to cardiovascular disease in hypopituitarism
5. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors
6. Insulin-like growth factor-I and angiographically documented coronary artery disease
7. IGF-1 and ischemic heart disease in older people
8. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: Relation to cardiovascular risk factors and disease
9. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men
10. Changes of the insulin-like growth factor I system during acute myocardial infarction: Implications on left ventricular remodeling
11. Insulin-like growth factor-I, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X
12. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations
13. Trends in selected biological risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992
14. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand
15. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
16. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
18. Population-based reference values for IGF-I and IGF-binding protein-1: Relations with metabolic and anthropometric variables
19. The insulin-like growth factor axis and plasma lipid levels in the elderly
20. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
21. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: Beneficial effects of bezafibrate treatment
22. Reduced levels of insulin-like growth factor-I in patients with angina pectoris, positive exercise stress test, and angiographically normal epicardial coronary arteries
23. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients
24. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes
25. Effects of antihypertensive therapy on left ventricular hypertrophy of essential hypertension: A role for insulin-like growth factor I?
26. Biochemical correlates of aortic distensibility in vivo in normal subjects